Ventilator Associated Tracheobronchitis in the First 14 Days in ICU

Airway Colonization Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01802827
• Other study ID #: MARKAR236
• Status: Completed
• Phase: N/A
• First received: September 24, 2012
• Last updated: February 28, 2013
• Start date: June 2009
• Est. completion date: June 2011

Study information

• Verified date: February 2013
• Source: University of Thessaly
• Contact: n/a
• Is FDA regulated: No
• Health authority: Greece: Ethics Committee
• Study type: Observational

Clinical Trial Summary

To investigate the clinical course and risk factors for VAT and the impact of VAT on Intensive Care Unit (ICU) morbidity and mortality.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 236
• Est. completion date: June 2011
• Est. primary completion date: March 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• > 48 hours mechanical ventilation

Exclusion Criteria:

• immunodeficiency

• pregnancy

• severe COPD, chronic bronchitis, bronchiectasis

• recent pneumonia

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Airway Colonization
• Pneumonia
• Tracheobronchitis and Pneumonia Associated With Ventilator

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
University of Thessaly

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	mortality	we assessed mortality from all causes at 4 weeks	mortality at 4 weeks	No
Secondary	ICU length of stay		expected average length of stay 15 days	No
Secondary	mortality at 6 months		6 months	No